Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Xinda Biotechnology Co., Ltd. is a specialized biochemical enterprise headquartered in Heze, Shandong Province, China. The company focuses on the research, development, and large-scale production of animal-derived active pharmaceutical ingredients (APIs) and biological extracts. Its core product portfolio includes high-purity Chondroitin Sulfate, Heparin Sodium, and Pancreatin, which are essential for treating osteoarthritis, cardiovascular conditions, and digestive disorders. Operating under strict GMP standards, the company serves a global clientele across the pharmaceutical, nutraceutical, and healthcare sectors. Shandong Xinda is recognized as a National High-tech Enterprise, leveraging advanced extraction and purification technologies to maintain international quality standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Xinda Biotechnology.